Please login to the form below

Not currently logged in
Email:
Password:

ConfometRx

This page shows the latest ConfometRx news and features for those working in and with pharma, biotech and healthcare.

UCB signs research deal for novel neuroscience drugs

UCB signs research deal for novel neuroscience drugs

The Belgium-based biopharma firm is collaborating with ConfometRx, a California-based company that was co-founded by Stanford University professor and Nobel Prize winner Brian Kobilka. ... The two-year multi-target agreement will see UCB and ConfometRx

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics